MARKET

AIM

AIM

Aim Immunotech
AMEX
0.4710
+0.0280
+6.32%
After Hours: 0.4868 +0.0158 +3.35% 17:21 03/28 EDT
OPEN
0.4680
PREV CLOSE
0.4430
HIGH
0.4975
LOW
0.4465
VOLUME
424.04K
TURNOVER
0
52 WEEK HIGH
0.7487
52 WEEK LOW
0.3201
MARKET CAP
23.00M
P/E (TTM)
-1.0979
1D
5D
1M
3M
1Y
5Y
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
AIM ImmunoTech will present at the MedInvest Biotech & Pharma Investor Conference in New York, N.Y., on April 3, 2024. Thomas K. Equels, MS JD, will be the Chief Executive Officer of AIM. AIM will be presenting at the conference.
Barchart · 1d ago
Earnings Scheduled For March 26, 2024
Bluebird bio is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. AIM ImmunoTech is estimated to report earnings for its fourth quarter. Elbit Systems is projected to report. Quarterly earnings at $1.38 per share.
Benzinga · 2d ago
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
AIM ImmunoTech Inc. Will host a conference call and webcast to discuss the Company’s Q4/FY2023 operational and financial results on April 2, 2024. The conference call will be held at 8:30am ET on Tuesday, April 2.
Barchart · 3d ago
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. The Dow Jones index closed lower by over 300 points on Friday. Recent notable insider transactions for penny stocks include Citizens, Inc. And Brightcove Inc. Power Solutions International and AIM ImmunoTech are among the companies with recent insider transactions.
Benzinga · 3d ago
Weekly Report: what happened at AIM last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at AIM last week (0311-0315)?
Weekly Report · 03/18 10:24
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
Barchart · 03/15 07:45
Weekly Report: what happened at AIM last week (0304-0308)?
Weekly Report · 03/11 10:22
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules and Alferon N Injection (Interferon Alfa-N3). Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS) and is an experimental drug in the United States undergoing clinical development for the treatment of certain cancers and ME/CFS. Alferon N Injection is the registered trademark for its injectable formulation of natural alpha interferon. Alferon N Injection is a natural-source, multi-species alpha interferon approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.